Abramovitz; Mark
Patent Applications and Registrations
Patent applications and USPTO patent grants for Abramovitz; Mark.The latest application filed is for "prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer".
- Abramovitz; Mark - Dollard-des-Ormeaux N/A CA
- Abramovitz; Mark - Montreal CA
- Abramovitz; Mark - Dollar des Ormeaux CA
- Abramovitz; Mark - Quebec CA
- Abramovitz; Mark - Dollard de Ormeaux CA
| Patent | Date |
|---|---|
| Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer Grant 8,642,270 - Leyland-Jones , et al. February 4, 2 | 2014-02-04 |
| Prognostic Biomarkers To Predict Overall Survival And Metastatic Disease In Patients With Triple Negative Breast Cancer App 20100210738 - Leyland-Jones; Brian ; et al. | 2010-08-19 |
| Breast Cancer Gene Array App 20100087330 - Leyland-Jones; Brian ; et al. | 2010-04-08 |
| Methods of identifying modulators of a DP prostaglandin receptor Grant 6,395,499 - Abramovitz , et al. May 28, 2 | 2002-05-28 |
| DNA encoding prostaglandin receptor DP Grant 5,958,723 - Abramovitz , et al. September 28, 1 | 1999-09-28 |
| DNA encoding prostaglandin receptor FP Grant 5,869,281 - Abramovitz , et al. February 9, 1 | 1999-02-09 |
| Purified prostaglandin receptor FP Grant 5,840,847 - Abramovitz , et al. November 24, 1 | 1998-11-24 |
| Human Prostaglandin receptor IP Grant 5,728,808 - Abramovitz , et al. March 17, 1 | 1998-03-17 |
| DNA encoding human prostaglandin receptor EP2 Grant 5,605,814 - Abramovitz , et al. February 25, 1 | 1997-02-25 |
| DNA encoding prostaglandin receptor IP Grant 5,516,652 - Abramovitz , et al. May 14, 1 | 1996-05-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 